Healthcare Unfiltered

Radiopharmaceuticals: Resolving an Enigma

Aug 16, 2022
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 5min
2
Radiation Icology - First Time, but It's Not Going to Be the Last
04:45 • 2min
3
Therapeutic Therapy for Tumors
07:12 • 2min
4
Radium Two, 23 for Thyroid Cancer?
09:26 • 2min
5
I One 31 and Thyroid Cancer
11:16 • 2min
6
Ion 31 C Is Your Delivering Whole Body Radiation?
13:05 • 2min
7
Isotope Targeting for Thyroid Cancer?
15:16 • 2min
8
Prostate Specific Membrane Ingen
17:30 • 4min
9
Carabinet Study
21:34 • 2min
10
Is It a Peptide or a Biomolecule?
23:12 • 4min
11
Is There a Drug Resistance?
26:46 • 2min
12
The Linkers Do Matter
28:41 • 2min
13
Dosage of Lutetiumit
31:06 • 2min
14
Is Itrium or Liver?
32:57 • 3min
15
Dose Sphere Study
35:32 • 2min
16
The Challenges of M I B G
37:18 • 2min
17
Radiation Oncology
39:41 • 3min
18
Radiation Oncology
42:43 • 3min
19
Dose Activity Curves
45:59 • 2min
20
The Ludithera Is a Unique Treatment for a Benign Disease
47:37 • 4min
21
Nuclear Medicine
51:24 • 4min
22
Nuclear Medicine
55:49 • 3min
23
The Logistics Issues With Zeppelin and Bexar
58:27 • 3min
24
Zevelin
01:00:59 • 2min
25
Is There a Targeting Approach to Tumor Therapy?
01:02:47 • 2min
26
The Role of Radioactive Drugs in Prostate Cancer
01:05:10 • 2min
27
Molecular Targets
01:06:50 • 2min
28
Dose of Tumors and Toxicity
01:08:34 • 2min
29
The Cost of Radiation Therapy
01:10:38 • 2min
30
The Supply Chain and the Supply Chain
01:12:31 • 2min
31
Health Care Unfiltered Podcast Tea Shirt
01:14:29 • 3min